Venture Capital

The flight of promising biotech start-ups to Wisconsin does not bode well for Minnesota, a state that depends heavily on medical technology and devices for economic growth. Experts predict biotechnology will drive medical innovation over the next century and beyond. Wisconsin has become the regional...

Women CEOs of 18 early stage life science companies will gather at the Fluno Center in Madison on September 30th thru October 1st to compete for venture capital at the AllThingsLifeSciences 2009. Attendees will include regional and national investors seeking out promising early-stage companies. ...

The next 12-24 months should be interesting in the biotech and pharmaceutical industries. We have the large pharmaceutical companies holding onto a lot of cash. Yet, large pharma is very cognizant of the number of high profile drugs coming off U.S. patent soon....

An investor group said Wednesday it has acquired PKWare Inc., a Milwaukee software company that popularized a data compression system commonly referred to as "zipping." Novacap Technologies of Montreal was the lead investor and acquired the majority of PKWare's stock. Also participating were Maranon Capital...

Eighteen companies seeking investors have been selected by Springboard Enterprises to make pitches for venture capital at AllThingsLifeSciences 2009 in Madison next week. The forum is part of a two-day entrepreneurial program which also includes a seminar for aspiring entrepreneurs - Equity Matters: The...

Back in 1986, when Bill Gates was still making sales calls, he pitched my group at First Boston on why we should bet the farm on Windows. Despite the risk involved, we gave his fledgling startup the deal. This wasn’t because of his financial backers...

Venture capitalists are generally not thought of with great affection by most entrepreneurs, which should be no surprise given that venture capitalists turn entrepreneurs away far more often than they let open their checkbooks for them, and have at best ambiguous relationships with most of...

From one perspective, the life sciences industry — the biotechnology companies that develop drugs and treatments to combat disease and the biomedical firms that create medical devices — is a picture of expanding horizons and confidence, The New York Times’s James Flanigan writes. Young companies are...

Semba Biosciences Inc. has received a $250,000 Technology Venture Fund loan from the Wisconsin Department of Commerce for equipment and working capital to expand its capabilities into additional product lines and international distribution. ...